Corrigendum: Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008-2019
Saved in:
Main Authors: | Anna Maisa (Author), Christian Kollan (Author), Matthias an der Heiden (Author), Florian van Bömmel (Author), Markus Cornberg (Author), Stefan Mauss (Author), Heiner Wedemeyer (Author), Daniel Schmidt (Author), Sandra Dudareva (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008-2019
by: Anna Maisa, et al.
Published: (2021) -
Additional challenges in reaching hepatitis C elimination goals in Germany due to the COVID-19 pandemic - descriptive analysis of drug prescription data from January 2018 to June 2021
by: Emily D. Meyer, et al.
Published: (2023) -
Efficacy and its Predictors of Antiviral Therapy with Nucleos(T)Ide Analogs in Patients with Chronic Hepatitis B
by: T. H. Nguyen, et al.
Published: (2024) -
Long-acting prescriptions and therapy for HIV-1 from market launch to the present in Germany (May 2021 to December 2023)
by: Daniel Schmidt, et al.
Published: (2024) -
The Impact of Nucleos(t)ide Analogs Off-Therapy Among Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis
by: Mian Wang, et al.
Published: (2021)